Rhythm

George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension

Rhythm by 0 comments

George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood pressure treatments without additional side effects in earlier clinical research Lead candidate in Company’s pipeline of proprietary fixed-dose combination therapies targeting high unmet need in large patient populations suffering from non-communicable diseases such as CVD and Diabetes London, UK, 1 July 2021 – George Medicines, a late-stage drug development company focused […]

Continue Reading →

Vivalink Extends Medical Wearables Data Platform with Enhanced Temperature and Cardiac Monitors

Rhythm by 0 comments

Optimized for remote patient monitoring and decentralized clinical trials CAMPBELL, Calif., June 30, 2021 /PRNewswire/ — Vivalink, a leading provider of connected healthcare solutions known for its unique medical wearable sensor data platform, today announces a newly enhanced temperature and cardiac electrocardiogram (ECG) monitor. Adopted by over 100 healthcare application partners and customers […]

Continue Reading →

BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology

Rhythm by 0 comments

Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) — The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative […]

Continue Reading →

Vector to Debut Remote Cardiac Program Maturity Assessment at Heart Rhythm 2021

Rhythm by 0 comments

Constructive Feedback Helps Cardiology Practices Understand How to Improve their Remote Monitoring Programs BEND, Ore.–(BUSINESS WIRE)–Vector Remote Care announced today the launch of a Remote Cardiac Monitoring (RCM) Maturity Assessment to help cardiology practices understand both the current state of their program and how to grow and improve it to drive value […]

Continue Reading →

Alnylam Initiates KARDIA-1 Phase 2 Study of Zilebesiran (ALN-AGT) in Patients with Mild-to-Moderate Hypertension

Rhythm by 0 comments

– KARDIA-1 will Evaluate Efficacy and Safety of Quarterly and Biannual Regimens of Zilebesiran as Monotherapy – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of KARDIA-1, a global Phase 2 study evaluating the efficacy and safety of zilebesiran (pronounced “zile-BEE-siran” and formerly known […]

Continue Reading →

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

Rhythm by 0 comments

DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company’s first […]

Continue Reading →

Pulnovo Medical: a Pulmonary Arterial Hypertension medical device company completed the world’s first pulmonary hypertension treatment device RCT study after achieving FDA Breakthrough designation.

Rhythm by 0 comments

NANJING, China, June 28, 2021 /PRNewswire/ — Recently, Pulnovo Medical’s PADN-CFDA clinical trial, the world’s first pulmonary hypertension treatment device RCT study, has completed all patients enrollment, and will continue to assist each enrollment center to complete the follow-up of enrolled patients, data recovery, data cleaning, etc., and cooperate with the nation’s research […]

Continue Reading →

BioSig’s Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

Rhythm by 0 comments

Presentation to highlight clinical applications of the Company’s latest software for arrhythmia care Westport, CT, June 28, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range […]

Continue Reading →

Boston Scientific Exercises Option to Acquire Farapulse, Inc

Financial Rhythm by 0 comments

Acquisition complements company’s electrophysiology portfolio to include the only commercially available cardiac pulsed field ablation technology MARLBOROUGH, Mass., June 24, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire the remaining shares of Farapulse, Inc. The acquisition will complement the existing Boston Scientific electrophysiology portfolio to include […]

Continue Reading →

Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER-901, Its Proprietary Inhaled Imatinib for the Treatment of Pulmonary Arterial Hypertension

Rhythm by 0 comments

Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none of which are disease-modifying Dosing of patients in Phase 1 trial is currently ongoing with results expected later this year Plans to enter Phase 2/3 Trials in early 2022 DURHAM, N.C., June 24, 2021 (GLOBE […]

Continue Reading →
1 … 89 90 91 92 93 … 182